Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan

Journal of Infectious Diseases

Volumn 187, Issue 1, 2003, Pages 134-138

  Lin, Yu Cheng ^a,b   Chang, Mei Hwei ^a   Ni, Yen Hsuan ^a   Hsu, Hong Yuan ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; SERODIAGNOSIS; TAIWAN; VACCINATION; VIRUS REPLICATION;

ADOLESCENT; CHILD; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; MALE; TAIWAN; VACCINATION;

EID: 0037219807     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345871     Document Type: Article

References (15)

1. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257:2597-603.
2. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 Years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796-800.
3. Coursaget P, Leboulleux D, Soumare M, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994; 21:250-4.
4. West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J 1994; 13:745-7.
5. Lee PI, Lee CY, Huang LM, Chang MH. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 1995; 126:716-21.
6. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: Results of a 10-year study. J Infect Dis 1997; 175:674-7.
7. Shih HH, Chang MH, Hsu HY, Lee PI, Ni YH, Chen DS. Long-term immune response of universal hepatitis B vaccination in infancy: A community-based study in Taiwan. Pediatr Infect Dis J 1999; 18:427-32.
8. Luo KX, Zhou R, He C, Liang ZS, Jiang S. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991; 35:55-9.
9. Marusawa H, Uemoto S, Hijikata M, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31:488-95.
10. Lee CY, Huang LM, Chang MH, et al. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen - Positive hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J 1991; 10:299-303.
11. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987; 257:2612-6.
12. Chang MH, Hsu HY, Ni YH, et al. Precore stop codon mutant in chronic hepatitis B virus infection in children: Its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen. J Hepatol 1998; 28:915-22.
13. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312-7.
14. Mele A, Tancredi F, Romanò L, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905-8.
15. Hou MC, Wu JC, Kuo BI, et al. Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan: The importance of extending vaccination to susceptible adults. J Infect Dis 1993; 167:938-41.